Artrya Limited (ASX:AYA)

Australia flag Australia · Delayed Price · Currency is AUD
1.035
+0.010 (0.98%)
Jul 25, 2025, 11:36 AM AEST
0.98%
Market Cap116.55M
Revenue (ttm)13.00K
Net Income (ttm)-14.56M
Shares Out113.71M
EPS (ttm)-0.18
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume42,429
Average Volume338,590
Open1.015
Previous Close1.025
Day's Range1.015 - 1.035
52-Week Range0.230 - 1.180
Beta0.28
RSI59.86
Earnings DateAug 29, 2025

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. [Read more]

Sector Healthcare
Founded 2018
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol AYA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.